SEC Form 4 · accession 0001209191-17-002449
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley L Campbell
Officer — Chief Operating Officer
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 9:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 3, 2017 | A | 74,525 | $0.00 | A | 127,475 | D | |
| Common StockF1 | Jan 3, 2017 | M | 100,000 | — | A | 227,475 | D | |
| Common Stock | Jan 3, 2017 | F | 50,950 | $5.13 | D | 176,525 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $5.13 | Jan 3, 2017 | A | 103,578 | A | — | Jan 3, 2027 | Common Stock | 103,578 | 103,578 | D |
| Restricted Stock UnitsF1,F3 | — | Jan 3, 2017 | M | 100,000 | D | — | — | Common Stock | 100,000 | 0 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 3, 2018. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2018, with the final installment vesting on January 1, 2021.
- F3On June 26, 2014, the reporting person was granted 100,000 restricted stock units, vesting in full on July 1, 2016.